Functional itch disorder or psychogenic pruritus: Suggested diagnosis criteria from the French Psychodermatology Group

Acta Dermato-Venereologica

Volumn 87, Issue 4, 2007, Pages 341-344

  Misery, Laurent ^a   Alexandre, Sophie ^b   Dutray, Sabine ^a   Chastaing, Myriam ^a   Consoli, Sylvie G ^c   Audra, Hubert ^b   Bauer, Domitille ^d   Bertolus, Sylviane ^c   Callot, Valérie ^c   Cardinaud, Fabienne ^c   Corrin, Eliane ^c   Feton Danou, Nathalie ^c   Malet, Robert ^c   Touboul, Sylviane ^c   Consoli, Silla M ^e  

^a BREST UNIVERSITY HOSPITAL   (France)

^b Lyon University Hospital   (France)

^c Nantes University Hospital ^*

^d NANTES UNIVERSITY HOSPITAL   (France)

^e HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Functional; Itch; Pruritus; Psychogenic; Somatoform

Indexed keywords

PSYCHOTROPIC AGENT;

ABSENCE OF SOMATIC CAUSE; ARTICLE; CHRONIC PRURITUS; CLASSIFICATION; DERMATOLOGY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC CRITERIA; FUNCTIONAL ITCH DISORDER; LIFE EVENT; LOCALIZED PRURITUS SINE MATERIA; PRIORITY JOURNAL; PRURITUS; PSYCHODERMATOLOGY; PSYCHOGENIC PAIN; PSYCHOGENIC PRURITUS; PSYCHOLOGICAL ASPECT; PSYCHOTHERAPY; SOMATOFORM DISORDER; STANDARD; STRESS; CIRCADIAN RHYTHM; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; HOSPITALIZATION; HUMAN; MENTAL STRESS; NOMENCLATURE; PSYCHOSOMATIC DISORDER; REST;

CIRCADIAN RHYTHM; HUMANS; LIFE CHANGE EVENTS; PRURITUS; PSYCHOPHYSIOLOGIC DISORDERS; REST; SEVERITY OF ILLNESS INDEX; SOMATOFORM DISORDERS; STRESS, PSYCHOLOGICAL; TERMINOLOGY;

EID: 35348879137     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0266     Document Type: Article

References (27)

1. Yosipovitch G, Greaves MW, Schmelz M. Itch. Lancet 2003; 361: 690-694.
2. Biro T, Ko MC, Bromm B, Wei ET, Bigliardi P, Siebenhaar F, et al. How best to fight that nasty itch - from new insights into the neuroimmunological, neuroendocrine, and neurophysiological bases of pruritus to novel therapeutic approaches. Exp Dermatol 2005; 14, Suppl. 3: 225-240.
3. Misery L. Traitement symptomatique du prurit. Ann Dermatol Venereol 2005; 132: 492-495.
4. Misery L. Voies spécifiques du prurit ? Ann Dermatol Venereol 2005; 132: 1007.
5. Darsow U, Drzezga A, Frisch M, Munz F, Weilke F, Bartenstein P, et al. Processing of histamine-induced itch in the human cerebral cortex: a correlation analysis with dermal reactions. J Invest Dermatol 2000; 115: 1029-1033.
6. Drzezga A, Darsow U, Treede RD, Siebner H, Frisch M, Munz F, et al. Central activation by histamine-induced itch: analogies to pain processing: a correlational analysis of O-15 H2O positron emission tomography studies. Pain 2001; 92: 295-305.
7. Mochizuki H, Tashiro M, Kano M, Sakurada Y, Itoh M, Yanai K. Imaging of central itch modulation in the human brain using positron emission tomography. Pain 2003; 105: 339-346.
8. Walter B, Sadlo MN, Kupfer J, Niemeier V, Brosig B, Stark R, et al. Brain activation by histamine prick test-induced itch. J Invest Dermatol 2005; 125: 380-382.
9. Savin JA. How should we define itching? J Am Acad Dermatol 1998; 39: 268-269.
10. Paus R, Schmelz M, Biro T, Steinhoff M. Frontiers in pruritus research: scratching the brain for more effective itch therapy. J Clin Invest 2006; 116: 1174-1185.
11. van Os-Medendorp H, Eland-de Kok PCM, Grypdonck M, Bruijnzeel-Koomen CA, Ros WJG. Prevalence and predictors of psychosocial morbidity in patients with chronic pruritic skin. J Eur Acad Dermatol Venereol 2006; 20: 810-817.
12. Niemeier V, Kupfer J, Gieler U. Observations during an itch-inducing lecture. Dermatol Psychosom 1999; 1: 15-19.
13. Krishnan A, Koo J. Psyche, opioids, and itch: therapeutic consequences. Dermatol Ther 2005: 314-322.
14. Arnold LM, Auchenbach MB, Mac Elroy SL. Psychogenic excoriation: clinical features, proposed diagnostic criteria, epidemiology and approaches to treatment. CNS Drugs 2001; 15: 351-359.
15. Anzieu D, editor. Le moi-peau. Paris: Bordas, 1985.
16. Gupta MA, Gupta AK. Medically unexplained cutaneous sensory symptoms may represent somatoform dissociation: an empirical study. J Psychosom Res 2006; 60: 131-136.
17. Misery L, Chastaing M. Joint consultation by a psychiatrist and a dermatologist. Dermatol Psychosom 2003; 4: 160-164.
18. Consoli SG, editor. Psychiatrie et dermatologie. Paris: Elsevier, 2001.
19. Koblenzer CS. Psychosomatic concepts in dermatology. Arch Dermatol 1983; 119: 501-512.
20. Radmanesh M, Shafiei S. Underlying psychopathologies of psychogenic pruritic disorders. Dermatol Psychosom 2001; 2: 130-133.
21. Fried RG. Evaluation and treatment of "psychogenic" pruritus and self-excoriation. J Am Acad Dermatol 1994; 30: 993-999.
22. Gieler U, Niemeier V, Brosig B, Kupfer J. Psychosomatic aspects of pruritus. Dermatol Psychosom 2002; 3: 6-13.
23. Stangier U, Gieler U. Somatoforme Störungen in der Dermatologie. Psychotherapie 1997; 2: 91-101.
24. King SA. Review: DSM-IV and pain. Clin J Pain 1995; 11: 171-176.
25. Boland RJ. How could the validity of the DSM-IV pain disorder be improved in reference to the concept that it is supposed to identify? Curr Pain Headache Reports 2002; 6: 23-29.
26. Aronoff GM, Tota-Faucette M, Phillips L, Lawrence CN. Are pain disorder and somatization disorder valid diagnostic entities? Curr Rev Pain 2000; 4: 309-312.
27. Mayou R, Levenson J, Sharpe M. Somatoform disorders in DSM-V. Psychosomatics 2003; 44: 449-451.